v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Cash Flows from Operating Activities:      
Net loss $ (3,320,256) $ (859,032)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depletion, depreciation, amortization, and accretion 198,409 244,044  
Change in fair value of derivative asset 15,403    
Change in fair value of derivative liability (190,977)    
Deferred income tax benefit   (281,370)  
Amortization of debt discount and debt issuance costs 1,160,447    
Accrued interest expense on note payable and other current liabilities 42,515 43,094  
Interest income on investments and notes receivable (15,380) (16,594)  
Changes in operating assets and liabilities:      
Accounts receivables (320,869) 20,638  
Prepaid expenses and other assets 89,675 (210,847)  
Accounts payable (602,384) 577,864  
Accrued expenses 84,905 (14,174)  
Due to related parties 14,185 204,151  
Other liabilities -current 14,133 (27,238)  
Net cash used in operating activities (2,830,194) (319,464)  
Cash Flows from Investing Activities:      
Investment in property, plant and equipment, net (677,547) (200,000)  
Investment in oil and natural gas properties   (29,996)  
Net cash used in investing activities (677,547) (229,996)  
Cash Flows from Financing Activities:      
Issuance of common stock 2,198,443 12,000  
Proceeds from note payable   494,528  
Proceeds from convertible note, net of transaction costs 2,790,000    
Repayment on convertible notes (1,416,667)    
Debt issuance costs (84,183)    
Proceeds from related party   50,000  
Net cash provided by financing activities 3,487,593 556,528  
Net Change in Cash and cash equivalents (20,148) 7,068  
Cash and cash equivalents - Beginning of period 1,053,744 120,010 $ 120,010
Cash and cash equivalents - End of period 1,033,596 127,078 $ 1,053,744
Supplemental cash flow information:      
Cash interest payments $ 260,093 $ 16,921